|
| Interactions: | Atracurium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Soframycin - Ocular and Atracurium if possible. Concurrent use of Soframycin - Ocular and Atracurium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Pancuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Soframycin - Ocular and Pancuronium if possible. Concurrent use of Soframycin - Ocular and Pancuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Pipecuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Soframycin - Ocular and Pipecuronium if possible. Concurrent use of Soframycin - Ocular and Pipecuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status.
Vecuronium
Adverse Effect: enhanced and/or prolonged neuromuscular blockade which may lead to respiratory depression and paralysis Clinical Management: Avoid concomitant use of Soframycin - Ocular and Vecuronium if possible. Concurrent use of Soframycin - Ocular and Vecuronium requires close monitoring of the patients clinical condition, especially respiratory and oxygenation status. |
|
|